Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
80.9M
-
Shares change
-
+999K
-
Total reported value, excl. options
-
$1.69B
-
Value change
-
+$34.6M
-
Put/Call ratio
-
0.32
-
Number of buys
-
86
-
Number of sells
-
-48
-
Price
-
$20.88
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2020
164 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.9M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.8M shares), Avoro Capital Advisors LLC (7.59M shares), Versant Venture Management, LLC (7M shares), RTW INVESTMENTS, LP (6.79M shares), BlackRock Inc. (5.91M shares), Sonic Fund II, L.P. (4.11M shares), VANGUARD GROUP INC (3.85M shares), STATE STREET CORP (3.48M shares), ORBIMED ADVISORS LLC (3.29M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.12M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.